PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers

Clinical trial NCT04209595 · COMPLETED

Trial details

NCT number: NCT04209595
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extra-Pulmonary Small Cell Carcinomas

Start date: 2020-04-08
Primary completion: 2021-08-13
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.